The studies are likely to be a big focus of debate at a three-day FDA advisory panel meeting scheduled to begin early on the morning of Wednesday, Feb. 16, to decide the fate of Celebrex, Bextra and other Cox-2 drugs under development, such as Merck's Arcoxia.

FORBES: More Pain For Pfizer

He himself doesn't face re-election for another two years, but the congressional elections which take place on November 5th the day before the Fed meeting will have a big impact on the second half of his presidency.

ECONOMIST: Still on amber | The

Next week the big factor for the financial markets, metals included, will be the two-day Federal Reserve monetary policy meeting, set for Sept. 20-21.

FORBES: METALS OUTLOOK: Gold Weakness Could Continue Next Week